The artificial pancreas: Making headway

Practical Diabetes International

Volumn 24, Issue 2, 2007, Pages 56-58

  Hovorka, Roman ^a   Wilinska, Malgorzata E ^a   Chassin, Ludovic J ^a   Acerini, Carlo L ^a   Dunger, David B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN ASPART; INSULIN LISPRO;

ARTICLE; ARTIFICIAL PANCREAS; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; COMPUTER PROGRAM; CONTINUOUS INFUSION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; GLUCOSE TRANSPORT; HEALTH CARE COST; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MICROCOMPUTER; MONITOR; MORNING DOSAGE; RISK REDUCTION;

EID: 35649028507     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.1051     Document Type: Article

References (14)

1. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabetic Med 2006; 23: 1-12.
2. JDRF Artificial Pancreas Project. http://www.jdrf.org/ index.cfm?page_id=104576 [accessed 17 Jan 2007], 2007.
3. Steil GM, Rebrin I,, Darwin C, et al. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006; 55: 3344-3350.
4. Hovorka R, Chassin LJ, Wilinska ME, et al. Closing the loop: The Adicol experience. Diabetes Technol Ther 2004; 6: 307-318.
5. Hovorka R, Wilinska ME, Chassin LJ, et al. Roadmap to the artificial pancreas. Diabetes Res Clin Pract 2006; 74(Suppl 2): S178-S182.
6. Wilinska ME, Bodelenz M, Chassin LJ, et al. Interstitial glucose kinetics in subjects with Type 1 diabetes under physiologic conditions. Metab Clin Exp 2004; 53: 1484-1492.
7. Klonoff DC. Continuous Glucose Monitoring: Roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231-1239.
8. Plank J, Wutte A, Brunner G, et al. A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes. Diabetes Care 2002; 25: 2053-2057.
9. Renard E, Costalat G, Chevassus H, et al. Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab 2006; 32: 497-502.
10. Smith D, Amiel SA. Hypoglycaemia unawareness and the brain. Diabetologia 2002; 45: 949-958.
11. Hovorka R, Canonico V, Chassin LJ, et al. Non-linear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas 2004; 25: 905-920.
12. Feldman B, Brazg R, Schwartz S, et al. A continuous glucose sensor based on wired enzyme technology - results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 2003; 5: 769-779.
13. Weinzimer SA, Steil GM, Kurtz N, et al. Automated feedback-controlled insulin delivery in children with type 1 diabetes mellitus (T1D): A preliminary report. Diabetes 2006; 55(Suppl 1): A102.
14. Pham M. DexCom - Company report. New York, HSBC Securities (USA) Ltd, 2006.